July 2025 FDA Recall Sodium Bicarbonate by Exela Pharma Sciences Llc
D-0620-2025 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Exela Pharma Sciences Llc on July 30, 2025 for the product Sodium Bicarbonate. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0620-2025

Reason for Recall
Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.
Initiated
07-30-2025
Reported
09-17-2025
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Exela Pharma Sciences LLC
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Nationwide in the USA
4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton)

Batch or Lot Expiration Information

Lot# 10004077, Exp. 02/28/2026